📰 Immunization Practices News
Page 17 - Immunization Practices News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Immunization Practices. Real-time updates on events, politics, business and more.
December 7, 2023
A member of a key CDC advisory body told CNBC Friday morning that he expects the U.S. hiatus on Johnson & Johnson's one-off coronavirus vaccine to be
December 7, 2023
Antibodies from Vaccine Remain Two Years Out
December 6, 2023
Overall, the study authors concluded that the immunogenicity of quadrivalent influenza vaccines (QIV) and trivalent inactivated influenza vaccines (TIV) was similar for common influenza ingredients for children ages 6 to 35 months.
December 5, 2023
Experts see some significant benefits of applying mRNA technology to the production of flu vaccine — but also some serious challenges.
December 5, 2023
BALLSTON SPA, N.Y. — The Saratoga County Department of Health will hold a free vaccination clinic for Saratoga County seniors on Thursday, Dec. 7, 2023, from 9 a.m. to noon at the Saratoga County Public Safety Building at 6012 County Farm Road. Appointments are required and can be made by calling (518) 885-2276. Walk-ins cannot […]
December 1, 2023
ZeroHedge - On a long enough timeline, the survival rate for everyone drops to zero
November 30, 2023
A new GSK survey shows a large number of adults do not understand how shingles may be triggered1 More than half of adults surveyed incorrectly believe that you...
November 30, 2023
(BPT) - "Influenza took our child Emily from us."Joe Lastinger and his wife had no idea how serious flu could be. When their 3-year-old daughter Emily got sick, they took her to the doctor right away where a test confirmed she had influenza (flu). They...
November 30, 2023
(BPT) - "Influenza took our child Emily from us."Joe Lastinger and his wife had no idea how serious flu could be. When their 3-year-old daughter Emily got sick, they took her to the doctor right away where a test confirmed she had influenza (flu). They...
November 29, 2023
Arexvy is indicated for the prevention of RSV-lower respiratory tract disease in individuals aged 60 years and older.